IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis

BACKGROUND: Fosfomycin has the potential to be re-purposed as part of a combination therapy to treat neonatal sepsis where resistance to current standard of care (SOC) is common. Limited data exist on neonatal fosfomycin pharmacokinetics and estimates of bioavailability and CSF/plasma ratio in this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Kane, Zoe, Gastine, Silke, Obiero, Christina, Williams, Phoebe, Murunga, Sheila, Thitiri, Johnstone, Ellis, Sally, Correia, Erika, Nyaoke, Borna, Kipper, Karin, van den Anker, John, Sharland, Mike, Berkley, James A, Standing, Joseph F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212774/
https://ncbi.nlm.nih.gov/pubmed/33855449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkab083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados